Clofarabine‐based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience

This publication has 17 references indexed in Scilit:

• Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
  British Journal of Haematology, 2011
• Remission re‐induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia
  Pediatric Blood & Cancer, 2010
• Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series
  Leukemia & Lymphoma, 2009
• Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia
  British Journal of Haematology, 2009
• A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
  Leukemia, 2009
• Outcome of adults with acute lymphocytic leukemia after second salvage therapy
  Cancer, 2008
• A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias
  Blood, 2007
• Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
  Blood, 2006
• Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
  Journal of Clinical Oncology, 2006
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958